The expression of aversion to medicines in general practice consultations

Social Science & Medicine
Nicky BrittenColin Bradley

Abstract

Although the relevance of patients' views about medicines for their medicine taking behaviour is now well established, little is known about the ways in which these views are discussed in primary care consultations. In particular, many studies have demonstrated patients' aversion to medicines. This paper examines the form that aversion talk takes in the consultation and how doctors respond to patients' expression of aversion to medicines. It is based on a dataset of 35 case studies of general practice consultations in England. In interviews with researchers, aversion to medicines was expressed in 34 of the 35 cases. In consultations with doctors, aversion was expressed in 10 cases. The interactional dimension of aversion talk in consultations was analysed using Conversation Analysis, and two general patterns were identified. Aversion could be used as an interactional resource, or it could be a topic in its own right. If used as an interactional resource, no real discussion of patients' views of medicines took place. When aversion was a conversational topic in its own right, two situations were observed. Firstly, the doctor elicited patients' views directly. Secondly, patients initiated aversive talk using a range of indirect st...Continue Reading

References

Mar 1, 1992·Social Science & Medicine·J L Donovan, D R Blake
Jan 1, 1985·Social Science & Medicine·P Conrad
Sep 1, 1984·The Journal of Comparative Neurology·K Bulloch, W Pomerantz
Jul 1, 1997·Social Science & Medicine·S AdamsA Jones
Mar 4, 2000·BMJ : British Medical Journal·N BrittenC P Bradley
Mar 1, 2000·Social Science & Medicine·F A StevensonC P Bradley
May 8, 2000·BMJ : British Medical Journal·C A BarryN Barber

❮ Previous
Next ❯

Citations

Apr 4, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sylvie Fainzang
Jul 10, 2007·European Journal of Clinical Pharmacology·Juliet M FosterLolkje de Jong-van den Berg
Dec 13, 2005·Journal of General Internal Medicine·Jane L GivensFrances K Barg
May 11, 2005·BMJ : British Medical Journal·Trisha Greenhalgh
Jul 29, 2006·BMC Medical Research Methodology·Mary Dixon-WoodsAlex J Sutton
Oct 26, 2006·Respiratory Research·Juliet M FosterThys van der Molen
Jun 1, 2011·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Peri J BallantyneJudith E Fisher
Apr 28, 2005·Health Communication·William Evans
Sep 26, 2012·Social Psychiatry and Psychiatric Epidemiology·Alan QuirkClive Seale
Jul 14, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Eleanor T LewisJodie A Trafton
May 26, 2007·Patient Education and Counseling·David E Ness, Scott F Kiesling
May 1, 2008·Sociology of Health & Illness·Simon J WilliamsDeborah Lynn Steinberg
Aug 5, 2015·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Janet M Y CheungBandana Saini
Jul 19, 2005·Patient Education and Counseling·Peter Salmon, Bridget Young
Jan 17, 2015·Research in Social & Administrative Pharmacy : RSAP·Taehwan ParkMark L Davison
Nov 3, 2010·Patient Education and Counseling·Dianne LoweSophie Hill
Oct 2, 2007·Social Science & Medicine·Fiona Stevenson, Pia Knudsen
Sep 27, 2013·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Charleston Ribeiro PintoAdelmir Souza-Machado
Jul 31, 2008·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Sarah HetrickSally Merry
Oct 14, 2006·Qualitative Health Research·Dana Lee Hansen, Ebba Holme Hansen
Aug 7, 2009·Chronic Illness·Jörg W Haslbeck, Doris Schaeffer
Oct 11, 2005·Scandinavian Journal of Public Health. Supplement·Patricia E Deegan
Aug 7, 2016·Therapeutic Advances in Drug Safety·Rebecca Ryan, Sophie Hill
Sep 22, 2012·Journal of Psychiatric Practice·Mary V Seeman, Neil Seeman
Nov 18, 2005·Family Practice·Anja KapmeyerWolfgang Himmel
Dec 7, 2013·Expert Review of Vaccines·Jeremy Ward, Jocelyn Raude
Apr 30, 2014·The Cochrane Database of Systematic Reviews·Rebecca RyanMichael Taylor
Aug 16, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Srividya IyerAshok Malla
Oct 28, 2008·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Juliet M FosterEric van Sonderen
Sep 10, 2013·Journal of Cross-cultural Gerontology·Peri J BallantyneHeather Boon
Aug 5, 2021·Academic Medicine : Journal of the Association of American Medical Colleges·Jacquelin ForseyNicole N Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.